rine) and the Turkish study 36 (which compared a combination of oxytocin and misoprostol with no uterotonic), was Cochrane OR 0.75 (95% CI 0.49–1.14) for severe PPH, very similar to our results from all studies (OR 0.74, 95% CI 0.52–1.04), although our adequate-quality studies showed a stronger and highly significant effect (OR 0.67, 95% CI 0.51–0.89).
← all excerpts
What measured blood loss tells us about postpartum bleeding: a systematic review.
2
—
—
The sentences
The association with severe PPH is marginally significant (OR 0.76, 95% CI 0.52–1.09).